Pharmaceuticals

How AI is advancing drug reinvention: Q&A with Dr. Friso Postma

bexib
By bexib 0 Min Read

BioXcel’s VP of AI Drug Discovery discusses how use of the technology has advanced over the past year.

You Might Also Like

Competitors take aim at KarXT as decision date approaches

Movano Health Announces Addition of Deep Learning Software to Its AI-Powered Heart Rate Monitoring Software

Pharma Pulse 9/10/24: Why satellite sites outperform decentralized models, number of people with clinical indications for GLP-1 drugs, and more

The researchers mapped the interactions of 144 active substances to identify their medicinal properties.

Pharma Pulse 8/30/24: Efforts to expand access and diversity, why “normal” remains a crisis, and more

Share This Article
Previous Article How to Decide Whether to Handle Subscription Box Fulfillment In-House or Outsource (2024)
Next Article If your crops are growing slowly, beware of flea beetles – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Sri Lanka’s Ugauragara provides a memorable outdoor dining experience called “Ugauragara no Kamata”.
Hospitality & Tourism
FinTech financing: Datadirect Networks has $ 300 million
Banking
CFPB imposes a fine of $ 2.5 million in Fintech Wise
Banking
Within the city’s cloud migration strategy
Banking